Logo image of HALO

HALOZYME THERAPEUTICS INC (HALO) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:HALO - US40637H1095 - Common Stock

63.33 USD
+0.38 (+0.6%)
Last: 12/5/2025, 8:25:42 PM
63.33 USD
0 (0%)
After Hours: 12/5/2025, 8:25:42 PM
Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to HALO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 77.52. This target is 22.41% above the current price.
HALO was analyzed by 15 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about HALO.
In the previous month the buy percentage consensus was at a similar level.
HALO was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
HALO Historical Analyst RatingsHALO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -108 -98 -88 -78 -68 -58 -48 -38 -28 -18 -8 5 10 15

Price Target & Forecast

Price Low Median Mean High 63.3356.5678.5477.5296.60 - -10.69% 24.02% 22.41% 52.53%
HALO Current Analyst RatingHALO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-11-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-11-18 Goldman Sachs Maintains Neutral -> Neutral
2025-11-04 Citizens Maintains Market Outperform -> Market Outperform
2025-10-27 JP Morgan Maintains Neutral -> Neutral
2025-10-20 Morgan Stanley Maintains Overweight -> Overweight
2025-10-15 HC Wainwright & Co. Reiterate Buy -> Buy
2025-10-14 Leerink Partners Upgrade Underperform -> Market Perform
2025-10-02 HC Wainwright & Co. Maintains Buy -> Buy
2025-09-24 Benchmark Maintains Buy -> Buy
2025-09-22 HC Wainwright & Co. Maintains Buy -> Buy
2025-08-18 Morgan Stanley Maintains Overweight -> Overweight
2025-08-07 JP Morgan Maintains Neutral -> Neutral
2025-08-06 JMP Securities Maintains Market Outperform -> Market Outperform
2025-08-06 Morgan Stanley Upgrade Equal-Weight -> Overweight
2025-08-06 HC Wainwright & Co. Maintains Buy -> Buy
2025-07-16 JP Morgan Maintains Neutral -> Neutral
2025-05-29 HC Wainwright & Co. Reiterate Buy -> Buy
2025-05-14 Morgan Stanley Downgrade Overweight -> Equal-Weight
2025-05-13 Leerink Partners Downgrade Market Perform -> Underperform
2025-05-07 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2025-04-25 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-21 JP Morgan Maintains Neutral -> Neutral
2025-03-06 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-20 Benchmark Reiterate Buy -> Buy
2025-02-19 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-13 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2025-01-10 Piper Sandler Maintains Neutral -> Neutral
2025-01-10 HC Wainwright & Co. Maintains Buy -> Buy
2024-12-30 HC Wainwright & Co. Reiterate Buy -> Buy

HALOZYME THERAPEUTICS INC / HALO FAQ

Can you provide the average price target for HALOZYME THERAPEUTICS INC stock?

15 analysts have analysed HALO and the average price target is 77.52 USD. This implies a price increase of 22.41% is expected in the next year compared to the current price of 63.33.


What is the consensus rating for HALO stock?

The consensus rating for HALOZYME THERAPEUTICS INC (HALO) is 77.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover HALOZYME THERAPEUTICS INC (HALO) stock?

The number of analysts covering HALOZYME THERAPEUTICS INC (HALO) is 15.